References

Cancer information / Cancer types / Prostate / Treatment / Chemotherapy

American Cancer Society. (2015, March 12). Prostate Cancer. Atlanta, GA: American Cancer Society. Retrieved from: http://www.cancer.org/acs/groups/cid/documents/webcontent/003134-pdf.pdf.

Cancer Research UK. (2014, February 25). About Chemotherapy for Prostate Cancer. Retrieved from: http://www.cancerresearchuk.org/about-cancer/type/prostate-cancer/treatment/chemotherapy/about-chemotherapy-for-prostate-cancer?view=PrinterFriendly.

Garnick MB (ed.). (2015). Harvard Medical School 2015 Annual Report on Prostate Diseases.

James ND, Sydes MR, Clarke NW, et al. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. (2016, March 19). Lancet. Elsevier. 387(10024):1163-77. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800035/pdf/main.pdf.

National Cancer Institute. (2015, August 7). Prostate Cancer Treatment for Health Professionals (PDQ®). Retrieved from: http://www.cancer.gov/types/prostate/hp/prostate-treatment-pdq.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer (Version 1.2016). Retrieved from: http://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf.

Princess Margaret Cancer Centre. (2015, October). Princess Margaret Cancer Centre Clinical Practice Guidelines: Prostate Cancer. Retrieved from: http://www.uhn.ca/PrincessMargaret/Health_Professionals/Programs_Departments/Genitourinary_GU/Documents/CPG_GU_Prostate.pdf.

Raghavan D, Chai Seungjean C, Mahoney J. Castrate resistant prostate cancer: Systemic chemotherapy and a system problem. Nargund VH, Raghavan D, Sandler HM (eds.). (2015). Urological Oncology. Springer. 49: 835-845.

Saad F, Chi KN, Finelli A, Hotte SJ, Izawa J, Kapoor A, et al. The 2015 CUA-CUOG Guidelines for the management of castration-resistant prostate cancer (CRPC). (2015, March-April). Canadian Urological Association Journal. 9(3-4):90-6. Retrieved from: https://www.cua.org/themes/web/assets/files/guidelines/en/cua-cuog-guidelines.pdf.

Scher HI, Scardino PT, Zelefsky. Cancer of the prostate. DeVita VT Jr, Lawrence TS, Rosenberg SA. (2015). Cancer: Principles and Practice of Oncology. (10th Edition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 68:932-980.

Sweeney CJ, Chen YH, Carducci M, et al. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer. (2015, August 20). New England Journal of Medicine. 373(8):737-46. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562797/pdf/nihms719565.pdf.

×
×